CTRI/2024/08/071861尚未招募Unknown
Impact of Multiple Micronutrients Fortified Oral Nutrition Supplements on Physical Growth, Muscle Parameters, Strength, and Cognitive Development in School Aged Children (6-16 years): Randomized Controlled Comparative Study - NI
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Normal and mildly malnourished children with BMI-for-age percentiles [between 3rd to 25th percentile (-1.881) to (-0.674) z-score] by calculating as per WHO 5-19 years Growth Reference will be included
- •2.Screening for anemia will be done to include all children with hemoglobin =8 mg/dl
- •3.Children = 6 years to = 16 years will be included. (25-30 children per age). Stratification of pubertal (10 -15+ years) and prepubertal (6-9+ years) will be done later. Both boys and girls will be included
- •4.Children should not be lactose intolerant /have lactose sensitivity and be comfortable to have milk daily.
- •[0 – (-1 SD) are normal children; (-1 to -1.9 SD) is defined as mild malnutrition; [-2 to -2.9 SD) is defined as moderate malnutrition; [(= -3) is defined as severe malnutrition].
- •[mild anaemia defined as 11 – 11.49 and 11 – 11.99 mg/dl for children 5-11 years and 12-14 years respectively; moderate anaemia defined as 8 - 10.99 mg/dl for children 5-11 years and 12-14 years respectively]
排除标准
- •Children will be excluded at the time of screening, if they had been diagnosed or were known to:
- •1.be lactose intolerant and galactosaemic
- •2.be allergic or intolerant to wheat / any other cereal
- •3.have a current acute or chronic infection including but not restricted to respiratory infection, diarrhoea, Hepatitis B or C, HIV infection or tuberculosis.
- •4.have severe gastrointestinal disorders including celiac disease, short bowel syndrome, pancreatic insufficiency, or cystic fibrosis; have a diagnosis of neoplastic, renal, hepatic or cardiovascular disease, hormonal or metabolic disorders, congenital disease or genetic disorders such as atrial or ventricular wall defects, or Down’s syndrome, infantile anorexia nervosa, developmental disability, including physical disorders such as cerebral palsy, or developmental delay.
- •5.diagnosed with disorders of haemoglobin structure, function, or synthesis according to medical records or parent/guardian report, or
- •6.have been diagnose with ADHD, any form of delayed / impaired cognitive development, delayed developmental milestones, or is on any form of medication for other cognitive conditions.
- •7.have had a clinically significant nutritional deficiency requiring specific treatment with another similar nutritional supplement (other than the study product) or
- •8.have any other clinically significant medical condition, which, in the investigator’s opinion, made the child unsuitable for inclusion in the study.
研究者
相似试验
已完成
不适用
Micronutrient supplementation for improving micronutrient status in underweight and overweight/obese primary school childreAnaemiaMicronutrient status of primary school childrenUnderweightOverweight and obesityBlood - AnaemiaDiet and Nutrition - Other diet and nutrition disordersDiet and Nutrition - ObesityACTRN12616001245482Dr Ewa Szymlek-Gay348
招募中
2 期
The effect of oral nutrition supplement (ONS) on autologous hematopoietic stem cell transplantatioMultiple myelomaCondition 1: Lymphoma. Condition 2: multiple myeloma.Non-Hodgkin lymphoma, unspecifiedC85.9C90.0IRCT20220208053971N2Tehran University of Medical Sciences38
尚未招募
不适用
The effect of micronutrient supplementation in combination with healthy lifestyle coaching on nutrition status and well-being: A 6-month study in GhanaNutritional, Metabolic, EndocrinePACTR202402872415588Innonext150
已完成
2 期
Effect of oral nutrition supplement enriched with eicosapentaenoic acid (Prosure) on inflammatory response following colon cancer surgery: A Phase II randomized controlled studyColon CancerJPRN-UMIN000008434agoya City University100
招募中
不适用
Evaluation of effects of oral nutrition enriched with Eicosapentaenoic acid(EPA) in patients underwent neoadjuvant chemo therapy for head and neck cancer.Head and neck cancerJPRN-UMIN000007844Juntendo University school of medicine30
